Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jinghua Yan

Showing results (111-120 of 161) with videos related to

Pageof 17
Sort By:
Mabs|March 21, 2019
Glycosylation-independent binding of monoclonal antibody toripalimab to FG loop of PD-1 for tumor immune checkpoint therapyHongchuan Liu, Lijing Guo, Jing Zhang, et al.
Nature Communications|August 21, 2025
Highly scalable prefusion-stabilized RSV F vaccine with enhanced immunogenicity and robust protectionQingrui Huang, Qingyun Lang, Yao Li, et al.
Vaccine|September 18, 2017
Hemagglutinin-specific CD4<sup>+</sup> T-cell responses following 2009-pH1N1 inactivated split-vaccine inoculation in humansShuguang Tan, Shihong Zhang, Bin Wu, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 3, 2020
The structural basis of African swine fever virus pA104R binding to DNA and its inhibition by stilbene derivativesRuili Liu, Yeping Sun, Yan Chai, et al.
Cell Research|September 23, 2015
A humanized neutralizing antibody against MERS-CoV targeting the receptor-binding domain of the spike proteinYan Li, Yuhua Wan, Peipei Liu, et al.
ACS Nano|April 15, 2014
Analysis of influenza virus receptor specificity using glycan-functionalized gold nanoparticlesJinhua Wei, Longtang Zheng, Xun Lv, et al.
The Journal of Infectious Diseases|October 15, 2016
Cross-immunity Against Avian Influenza A(H7N9) Virus in the Healthy Population Is Affected by Antigenicity-Dependent SubstitutionsWilliam J Liu, Shuguang Tan, Min Zhao, et al.
Antiviral Research|January 2, 2017
Novel chimeric virus-like particles vaccine displaying MERS-CoV receptor-binding domain induce specific humoral and cellular immune response in miceChong Wang, Xuexing Zheng, Weiwei Gai, et al.
Nature Communications|February 7, 2017
An unexpected N-terminal loop in PD-1 dominates binding by nivolumabShuguang Tan, Hao Zhang, Yan Chai, et al.
Innovation (Cambridge (Mass.))|October 6, 2022
A neutralizing-protective supersite of human monoclonal antibodies for yellow fever virusYan Li, Zhihai Chen, Lili Wu, et al.
Pageof 17

Showing results (111-120 of 161) with videos related to

Sort By:
Pageof 17
Mabs|March 21, 2019
Glycosylation-independent binding of monoclonal antibody toripalimab to FG loop of PD-1 for tumor immune checkpoint therapyHongchuan Liu, Lijing Guo, Jing Zhang, et al.
Nature Communications|August 21, 2025
Highly scalable prefusion-stabilized RSV F vaccine with enhanced immunogenicity and robust protectionQingrui Huang, Qingyun Lang, Yao Li, et al.
Vaccine|September 18, 2017
Hemagglutinin-specific CD4<sup>+</sup> T-cell responses following 2009-pH1N1 inactivated split-vaccine inoculation in humansShuguang Tan, Shihong Zhang, Bin Wu, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 3, 2020
The structural basis of African swine fever virus pA104R binding to DNA and its inhibition by stilbene derivativesRuili Liu, Yeping Sun, Yan Chai, et al.
Cell Research|September 23, 2015
A humanized neutralizing antibody against MERS-CoV targeting the receptor-binding domain of the spike proteinYan Li, Yuhua Wan, Peipei Liu, et al.
ACS Nano|April 15, 2014
Analysis of influenza virus receptor specificity using glycan-functionalized gold nanoparticlesJinhua Wei, Longtang Zheng, Xun Lv, et al.
The Journal of Infectious Diseases|October 15, 2016
Cross-immunity Against Avian Influenza A(H7N9) Virus in the Healthy Population Is Affected by Antigenicity-Dependent SubstitutionsWilliam J Liu, Shuguang Tan, Min Zhao, et al.
Antiviral Research|January 2, 2017
Novel chimeric virus-like particles vaccine displaying MERS-CoV receptor-binding domain induce specific humoral and cellular immune response in miceChong Wang, Xuexing Zheng, Weiwei Gai, et al.
Nature Communications|February 7, 2017
An unexpected N-terminal loop in PD-1 dominates binding by nivolumabShuguang Tan, Hao Zhang, Yan Chai, et al.
Innovation (Cambridge (Mass.))|October 6, 2022
A neutralizing-protective supersite of human monoclonal antibodies for yellow fever virusYan Li, Zhihai Chen, Lili Wu, et al.
Pageof 17